Join to View Full Profile
Memorial Sloan Kettering Cancer Center Westchester500 Westchester AvenueNew York, NY 10021
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2011
University of Michigan Medical SchoolClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2019 - 2025
NY State Medical License 2011 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) Start of enrollment: 2017 Sep 06
- A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma Start of enrollment: 2018 Aug 13
Publications & Presentations
PubMed
- 1 citationsClinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.Jennifer Ma, Luke Del Balzo, Henry Walch, Sari Khaleel, Andrea Knezevic
European Urology Oncology. 2025-04-01 - Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma.Yasser Ged, Amina Touma, Luis Meza Contreras, Roy Elias, Joseph Van Galen
Journal of Immunotherapy. 2025-04-01 - A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma.Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, Rachel Jacobi, Hyung Jun Woo
European Urology Oncology. 2025-03-29
Press Mentions
7 Myths About Kidney Cancer, DebunkedApril 19th, 2023- Second-Line Metastatic RCC Outcomes Similar Regardless of First-Line Immunotherapy Combo PartnerNovember 14th, 2022
- What Is Kidney Cancer? Symptoms, Causes, Diagnosis, Treatment, and PreventionJune 12th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
